Stake:9.99%Shares: 0CUSIP: 576810303Class: Common Stock, $0.0001 par value per share
Item 4 — Purpose of Transaction
Item 4 of the Schedule 13D is hereby amended and supplemented by the addition of the following: The Reporting Persons' response to Item 5(c) is incorporated by reference into this Item 4.
Cross-References
Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
2 13D/G filings on this issuer
1 other filing besides this one
Filer Track Record
1 filings by this filer
0 other filings in the data moat
Short Interest · settle 2026-07-31
DTC 1.00
839,994 shares short · +77.3% vs prior
Other 13D/G Filings on Matinas BioPharma Holdings, Inc.